and Specific Aims.) This application is part of a long-term effort to characterize the basic mechanisms underlying the airway remodeling that occurs in patients with chronic diseases of the airways. A key step in this process is identification of the molecular mechanisms by which airway epithelial cells interact with the extracellular matrix. Integrins represent the largest known family of receptors for extracellular matrix proteins, and the homology-based polymerase chain reaction has been used to identify novel subunits of integrins. The goals of the present application are to characterize the tissue distribution, matrix protein ligand(s), and cellular function(s) of integrins containing one of these subunits, a9, and to examine expression of these receptors in airway biopsies of healthy human subjects and subjects with asthma in the presence or absence of superimposed airway injury and inflammation.
The Specific Aims are to: 1) complete the full length deduced amino acid sequence of a9 and to demonstrate that it encodes an integrin protein; 2) to identify and characterize the apparently novel b subunit partner of a9 in airway epithelial cells; 3) determine the cell and tissue distribution of a9 integrins; 4) determine the ligand(s) for a9 integrins; 5) determine the effects of a9 integrins on cell behavior; and 6) determine the expression and distribution of a9 in normal and asthmatic human airways before and after injury and inflammation. The results may shed light on the general process of epithelial-matrix interactions, and could provide insight into the molecular mechanisms underlying the airway remodeling that characterizes airway disease such as asthma.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL033259-09
Application #
3344958
Study Section
Lung Biology and Pathology Study Section (LBPA)
Project Start
1985-09-20
Project End
1998-08-31
Budget Start
1993-09-01
Budget End
1994-08-31
Support Year
9
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Liao, Yung-Feng; Gotwals, Philip J; Koteliansky, Victor E et al. (2002) The EIIIA segment of fibronectin is a ligand for integrins alpha 9beta 1 and alpha 4beta 1 providing a novel mechanism for regulating cell adhesion by alternative splicing. J Biol Chem 277:14467-74
Pittet, J F; Griffiths, M J; Geiser, T et al. (2001) TGF-beta is a critical mediator of acute lung injury. J Clin Invest 107:1537-44
Kaminski, N; Allard, J D; Pittet, J F et al. (2000) Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. Proc Natl Acad Sci U S A 97:1778-83
Huang, X; Griffiths, M; Wu, J et al. (2000) Normal development, wound healing, and adenovirus susceptibility in beta5-deficient mice. Mol Cell Biol 20:755-9
Sheppard, D (2000) In vivo functions of integrins: lessons from null mutations in mice. Matrix Biol 19:203-9
Huang, X Z; Wu, J F; Ferrando, R et al. (2000) Fatal bilateral chylothorax in mice lacking the integrin alpha9beta1. Mol Cell Biol 20:5208-15
Takahashi, H; Isobe, T; Horibe, S et al. (2000) Tissue transglutaminase, coagulation factor XIII, and the pro-polypeptide of von Willebrand factor are all ligands for the integrins alpha 9beta 1 and alpha 4beta 1. J Biol Chem 275:23589-95
Marcinkiewicz, C; Taooka, Y; Yokosaki, Y et al. (2000) Inhibitory effects of MLDG-containing heterodimeric disintegrins reveal distinct structural requirements for interaction of the integrin alpha 9beta 1 with VCAM-1, tenascin-C, and osteopontin. J Biol Chem 275:31930-7
Taooka, Y; Chen, J; Yednock, T et al. (1999) The integrin alpha9beta1 mediates adhesion to activated endothelial cells and transendothelial neutrophil migration through interaction with vascular cell adhesion molecule-1. J Cell Biol 145:413-20
Yokosaki, Y; Matsuura, N; Sasaki, T et al. (1999) The integrin alpha(9)beta(1) binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin. J Biol Chem 274:36328-34

Showing the most recent 10 out of 43 publications